2Department of Medicine, Washington University School of Medicine, St. Louis, Missouri. 8ICCE Institute, Washington University School of Medicine, St Louis, Missouri ...

Copyright held by the owner/author(s).

Abstract: Individualized drug screens were evaluated in a small, prospective study to guide treatment decisions for children with relapsed or refractory cancers, yielding enduring responses compared ...

Major Finding: A shared neoantigen vaccine plus immune checkpoint blockade was well-tolerated in advanced solid tumors. Concept: Preliminary clinical activity was observed along with a hierarchy of ...

Major Finding: Nonmalignant BRCA1/BRCA2-mutant breast tissues exhibit markers of immune infiltration and exhaustion. Approach: A single-cell atlas of the human breast maps changes influenced by age, ...

1Department of Pathology, Stanford University School of Medicine, Palo Alto, California.

1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 2Cancer Center, Massachusetts General Hospital, Harvard Medical School, ...

This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.

The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...

The primary treatment for glioblastoma (GBM) is removing the tumor mass as defined by magnetic resonance imaging (MRI). However, MRI has limited diagnostic and predictive value. Tumor-associated ...

1Sarah Cannon Research Institute, Nashville, Tennessee. *Corresponding Author: Vivek Subbiah, Sarah Cannon Research Institute, 335 24th Ave. N. Suite 300, Nashville ...

1Cancer Moonshot, White House, Office of Science and Technology Policy, Washington, District of Columbia. Search for other works by this author on: 1Cancer Moonshot, White House, Office of Science and ...